Background Type 2 diabetes mellitus (T2DM) patients commonly undergo metformin monotherapy. This study aims to compare the efficacy, safety, and tolerability of combination therapy of dapagliflozin plus linagliptin versus dapagliflozin plus vildagliptin as add-on therapy in T2DM patients inadequately controlled on metformin. Methodology This was an 18-week, multicenter, randomized, double-blind, active-controlled, parallel-group, phase III clinical study.
View Article and Find Full Text PDFContext: To find a single time point during clonidine stimulation test (CST), with highest diagnostic value to rule out growth hormone deficiency (GHD).
Settings And Design: This is a retrospective study of 79 CSTs carried out in a tertiary care center in India.
Materials And Methods: A cohort of 79 children with unexplained short stature was divided into two groups: GHD and non-GHD.